Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1995 Oct 1;311(Pt 1):1–16. doi: 10.1042/bj3110001

The toxicity in vitro of beta-amyloid protein.

L L Iversen 1, R J Mortishire-Smith 1, S J Pollack 1, M S Shearman 1
PMCID: PMC1136112  PMID: 7575439

Full text

PDF
1

Images in this article

1Figure 1
on p.1
3Figure 2
on p.3
4Figure 3
on p.4
6Figure 4
on p.6
13Figure 5
on p.13

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham C. R., Shirahama T., Potter H. Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. Neurobiol Aging. 1990 Mar-Apr;11(2):123–129. doi: 10.1016/0197-4580(90)90045-2. [DOI] [PubMed] [Google Scholar]
  2. Aisen P. S., Davis K. L. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry. 1994 Aug;151(8):1105–1113. doi: 10.1176/ajp.151.8.1105. [DOI] [PubMed] [Google Scholar]
  3. Altman F. P. Tetrazolium salts and formazans. Prog Histochem Cytochem. 1976;9(3):1–56. doi: 10.1016/s0079-6336(76)80015-0. [DOI] [PubMed] [Google Scholar]
  4. Araujo D. M., Cotman C. W. Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 1992 Jan 8;569(1):141–145. doi: 10.1016/0006-8993(92)90380-r. [DOI] [PubMed] [Google Scholar]
  5. Arispe N., Pollard H. B., Rojas E. Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10573–10577. doi: 10.1073/pnas.90.22.10573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Arispe N., Rojas E., Pollard H. B. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):567–571. doi: 10.1073/pnas.90.2.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Barrow C. J., Yasuda A., Kenny P. T., Zagorski M. G. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J Mol Biol. 1992 Jun 20;225(4):1075–1093. doi: 10.1016/0022-2836(92)90106-t. [DOI] [PubMed] [Google Scholar]
  8. Barrow C. J., Zagorski M. G. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. Science. 1991 Jul 12;253(5016):179–182. doi: 10.1126/science.1853202. [DOI] [PubMed] [Google Scholar]
  9. Behl C., Davis J. B., Klier F. G., Schubert D. Amyloid beta peptide induces necrosis rather than apoptosis. Brain Res. 1994 May 9;645(1-2):253–264. doi: 10.1016/0006-8993(94)91659-4. [DOI] [PubMed] [Google Scholar]
  10. Behl C., Davis J. B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 1994 Jun 17;77(6):817–827. doi: 10.1016/0092-8674(94)90131-7. [DOI] [PubMed] [Google Scholar]
  11. Behl C., Davis J., Cole G. M., Schubert D. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun. 1992 Jul 31;186(2):944–950. doi: 10.1016/0006-291x(92)90837-b. [DOI] [PubMed] [Google Scholar]
  12. Behl C., Hovey L., 3rd, Krajewski S., Schubert D., Reed J. C. BCL-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein. Biochem Biophys Res Commun. 1993 Dec 15;197(2):949–956. doi: 10.1006/bbrc.1993.2571. [DOI] [PubMed] [Google Scholar]
  13. Berr C., Hauw J. J., Delaère P., Duyckaerts C., Amouyel P. Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. Neurosci Lett. 1994 Sep 12;178(2):221–224. doi: 10.1016/0304-3940(94)90763-3. [DOI] [PubMed] [Google Scholar]
  14. Berridge M. V., Tan A. S. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys. 1993 Jun;303(2):474–482. doi: 10.1006/abbi.1993.1311. [DOI] [PubMed] [Google Scholar]
  15. Blass J. P., Gibson G. E. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev Neurol (Paris) 1991;147(6-7):513–525. [PubMed] [Google Scholar]
  16. Blessed G., Tomlinson B. E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968 Jul;114(512):797–811. doi: 10.1192/bjp.114.512.797. [DOI] [PubMed] [Google Scholar]
  17. Brookes A. J., St Clair D. Synuclein proteins and Alzheimer's disease. Trends Neurosci. 1994 Oct;17(10):404–405. doi: 10.1016/0166-2236(94)90013-2. [DOI] [PubMed] [Google Scholar]
  18. Brunden K. R., Richter-Cook N. J., Chaturvedi N., Frederickson R. C. pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans. J Neurochem. 1993 Dec;61(6):2147–2154. doi: 10.1111/j.1471-4159.1993.tb07453.x. [DOI] [PubMed] [Google Scholar]
  19. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem. 1992 Jan 5;267(1):546–554. [PubMed] [Google Scholar]
  20. Burdon R. H., Gill V., Rice-Evans C. Reduction of a tetrazolium salt and superoxide generation in human tumor cells (HeLa). Free Radic Res Commun. 1993;18(6):369–380. doi: 10.3109/10715769309147503. [DOI] [PubMed] [Google Scholar]
  21. Busciglio J., Lorenzo A., Yankner B. A. Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol Aging. 1992 Sep-Oct;13(5):609–612. doi: 10.1016/0197-4580(92)90065-6. [DOI] [PubMed] [Google Scholar]
  22. Busciglio J., Lorenzo A., Yeh J., Yankner B. A. beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 1995 Apr;14(4):879–888. doi: 10.1016/0896-6273(95)90232-5. [DOI] [PubMed] [Google Scholar]
  23. Busciglio J., Yeh J., Yankner B. A. beta-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J Neurochem. 1993 Oct;61(4):1565–1568. doi: 10.1111/j.1471-4159.1993.tb13658.x. [DOI] [PubMed] [Google Scholar]
  24. Bush A. I., Pettingell W. H., Jr, Paradis M. D., Tanzi R. E. Modulation of A beta adhesiveness and secretase site cleavage by zinc. J Biol Chem. 1994 Apr 22;269(16):12152–12158. [PubMed] [Google Scholar]
  25. Bush A. I., Pettingell W. H., Multhaup G., d Paradis M., Vonsattel J. P., Gusella J. F., Beyreuther K., Masters C. L., Tanzi R. E. Rapid induction of Alzheimer A beta amyloid formation by zinc. Science. 1994 Sep 2;265(5177):1464–1467. doi: 10.1126/science.8073293. [DOI] [PubMed] [Google Scholar]
  26. Butterfield D. A., Hensley K., Harris M., Mattson M., Carney J. beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem Biophys Res Commun. 1994 Apr 29;200(2):710–715. doi: 10.1006/bbrc.1994.1508. [DOI] [PubMed] [Google Scholar]
  27. Cai X. D., Golde T. E., Younkin S. G. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science. 1993 Jan 22;259(5094):514–516. doi: 10.1126/science.8424174. [DOI] [PubMed] [Google Scholar]
  28. Candy J. M., Oakley A. E., Edwardson J. A. Amorphous aluminosilicates promote nucleation of amyloid beta protein and tachykinins. Biochem Soc Trans. 1993 Feb;21(1):53S–53S. doi: 10.1042/bst021053s. [DOI] [PubMed] [Google Scholar]
  29. Candy J. M., Oakley A. E., Klinowski J., Carpenter T. A., Perry R. H., Atack J. R., Perry E. K., Blessed G., Fairbairn A., Edwardson J. A. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet. 1986 Feb 15;1(8477):354–357. doi: 10.1016/s0140-6736(86)92319-6. [DOI] [PubMed] [Google Scholar]
  30. Carette B., Poulain P., Delacourte A. Electrophysiological effects of 25-35 amyloid-beta-protein on guinea-pig lateral septal neurons. Neurosci Lett. 1993 Mar 5;151(1):111–114. doi: 10.1016/0304-3940(93)90059-t. [DOI] [PubMed] [Google Scholar]
  31. Castano E. M., Prelli F., Wisniewski T., Golabek A., Kumar R. A., Soto C., Frangione B. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem J. 1995 Mar 1;306(Pt 2):599–604. doi: 10.1042/bj3060599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Caughey B., Raymond G. J. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol. 1993 Feb;67(2):643–650. doi: 10.1128/jvi.67.2.643-650.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Chartier-Harlin M. C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature. 1991 Oct 31;353(6347):844–846. doi: 10.1038/353844a0. [DOI] [PubMed] [Google Scholar]
  34. Cheung N. S., Small D. H., Livett B. G. An amyloid peptide, beta A4 25-35, mimics the function of substance P on modulation of nicotine-evoked secretion and desensitization in cultured bovine adrenal chromaffin cells. J Neurochem. 1993 Mar;60(3):1163–1166. doi: 10.1111/j.1471-4159.1993.tb03270.x. [DOI] [PubMed] [Google Scholar]
  35. Choi-Miura N. H., Ihara Y., Fukuchi K., Takeda M., Nakano Y., Tobe T., Tomita M. SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol. 1992;83(3):260–264. doi: 10.1007/BF00296787. [DOI] [PubMed] [Google Scholar]
  36. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A. Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., Selkoe D. J. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 1992 Dec 17;360(6405):672–674. doi: 10.1038/360672a0. [DOI] [PubMed] [Google Scholar]
  37. Clemens J. A., Stephenson D. T. Implants containing beta-amyloid protein are not neurotoxic to young and old rat brain. Neurobiol Aging. 1992 Sep-Oct;13(5):581–586. doi: 10.1016/0197-4580(92)90059-7. [DOI] [PubMed] [Google Scholar]
  38. Clements A., Walsh D. M., Williams C. H., Allsop D. Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide. Neurosci Lett. 1993 Oct 14;161(1):17–20. doi: 10.1016/0304-3940(93)90129-9. [DOI] [PubMed] [Google Scholar]
  39. Colaco C. A., Harrington C. R. Glycation: a pathological modification in neuropathies?: a hypothesis. Neuroreport. 1994 Apr 14;5(8):859–861. [PubMed] [Google Scholar]
  40. Come J. H., Fraser P. E., Lansbury P. T., Jr A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5959–5963. doi: 10.1073/pnas.90.13.5959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Copani A., Bruno V., Battaglia G., Leanza G., Pellitteri R., Russo A., Stanzani S., Nicoletti F. Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. Mol Pharmacol. 1995 May;47(5):890–897. [PubMed] [Google Scholar]
  42. Copani A., Koh J. Y., Cotman C. W. Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation. Neuroreport. 1991 Dec;2(12):763–765. doi: 10.1097/00001756-199112000-00008. [DOI] [PubMed] [Google Scholar]
  43. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr, Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994 Jun;7(2):180–184. doi: 10.1038/ng0694-180. [DOI] [PubMed] [Google Scholar]
  44. Coyle J. T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993 Oct 29;262(5134):689–695. doi: 10.1126/science.7901908. [DOI] [PubMed] [Google Scholar]
  45. Cummings B. J., Su J. H., Geddes J. W., Van Nostrand W. E., Wagner S. L., Cunningham D. D., Cotman C. W. Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer's disease. Neuroscience. 1992 Jun;48(4):763–777. doi: 10.1016/0306-4522(92)90265-4. [DOI] [PubMed] [Google Scholar]
  46. Davidson R. M., Shajenko L., Donta T. S. Amyloid beta-peptide (A beta P) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells. Brain Res. 1994 Apr 18;643(1-2):324–327. doi: 10.1016/0006-8993(94)90041-8. [DOI] [PubMed] [Google Scholar]
  47. Davis J. B., McMurray H. F., Schubert D. The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem Biophys Res Commun. 1992 Dec 15;189(2):1096–1100. doi: 10.1016/0006-291x(92)92317-q. [DOI] [PubMed] [Google Scholar]
  48. Deng H. X., Hentati A., Tainer J. A., Iqbal Z., Cayabyab A., Hung W. Y., Getzoff E. D., Hu P., Herzfeldt B., Roos R. P. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 1993 Aug 20;261(5124):1047–1051. doi: 10.1126/science.8351519. [DOI] [PubMed] [Google Scholar]
  49. Dudek S. M., Johnson G. V. Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide. Brain Res. 1994 Jul 18;651(1-2):129–133. doi: 10.1016/0006-8993(94)90688-2. [DOI] [PubMed] [Google Scholar]
  50. Durell S. R., Guy H. R., Arispe N., Rojas E., Pollard H. B. Theoretical models of the ion channel structure of amyloid beta-protein. Biophys J. 1994 Dec;67(6):2137–2145. doi: 10.1016/S0006-3495(94)80717-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Dyrks T., Dyrks E., Hartmann T., Masters C., Beyreuther K. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem. 1992 Sep 5;267(25):18210–18217. [PubMed] [Google Scholar]
  52. Dyrks T., Dyrks E., Masters C. L., Beyreuther K. Amyloidogenicity of rodent and human beta A4 sequences. FEBS Lett. 1993 Jun 14;324(2):231–236. doi: 10.1016/0014-5793(93)81399-k. [DOI] [PubMed] [Google Scholar]
  53. Elroy-Stein O., Bernstein Y., Groner Y. Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation. EMBO J. 1986 Mar;5(3):615–622. doi: 10.1002/j.1460-2075.1986.tb04255.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Emsley J., White H. E., O'Hara B. P., Oliva G., Srinivasan N., Tickle I. J., Blundell T. L., Pepys M. B., Wood S. P. Structure of pentameric human serum amyloid P component. Nature. 1994 Jan 27;367(6461):338–345. doi: 10.1038/367338a0. [DOI] [PubMed] [Google Scholar]
  55. Eriksson S., Janciauskiene S., Lannfelt L. Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation. Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2313–2317. doi: 10.1073/pnas.92.6.2313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., Ward P. J. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 1990 Jun 1;248(4959):1122–1124. doi: 10.1126/science.2111583. [DOI] [PubMed] [Google Scholar]
  57. Evans K. C., Berger E. P., Cho C. G., Weisgraber K. H., Lansbury P. T., Jr Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):763–767. doi: 10.1073/pnas.92.3.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Fabian H., Szendrei G. I., Mantsch H. H., Greenberg B. D., Otvös L., Jr Synthetic post-translationally modified human A beta peptide exhibits a markedly increased tendency to form beta-pleated sheets in vitro. Eur J Biochem. 1994 May 1;221(3):959–964. doi: 10.1111/j.1432-1033.1994.tb18811.x. [DOI] [PubMed] [Google Scholar]
  59. Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O., Tagliavini F. Neurotoxicity of a prion protein fragment. Nature. 1993 Apr 8;362(6420):543–546. doi: 10.1038/362543a0. [DOI] [PubMed] [Google Scholar]
  60. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Angeretti N. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport. 1993 May;4(5):523–526. doi: 10.1097/00001756-199305000-00015. [DOI] [PubMed] [Google Scholar]
  61. Fraser P. E., Lévesque L., McLachlan D. R. Biochemistry of Alzheimer's disease amyloid plaques. Clin Biochem. 1993 Oct;26(5):339–349. doi: 10.1016/0009-9120(93)90110-r. [DOI] [PubMed] [Google Scholar]
  62. Fraser P. E., McLachlan D. R., Surewicz W. K., Mizzen C. A., Snow A. D., Nguyen J. T., Kirschner D. A. Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues. J Mol Biol. 1994 Nov 18;244(1):64–73. doi: 10.1006/jmbi.1994.1704. [DOI] [PubMed] [Google Scholar]
  63. Fraser P. E., Nguyen J. T., Chin D. T., Kirschner D. A. Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. J Neurochem. 1992 Oct;59(4):1531–1540. doi: 10.1111/j.1471-4159.1992.tb08470.x. [DOI] [PubMed] [Google Scholar]
  64. Fraser P. E., Nguyen J. T., McLachlan D. R., Abraham C. R., Kirschner D. A. Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro. J Neurochem. 1993 Jul;61(1):298–305. doi: 10.1111/j.1471-4159.1993.tb03568.x. [DOI] [PubMed] [Google Scholar]
  65. Fraser P. E., Nguyen J. T., Surewicz W. K., Kirschner D. A. pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J. 1991 Nov;60(5):1190–1201. doi: 10.1016/S0006-3495(91)82154-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Friedlich A. L., Butcher L. L. Involvement of free oxygen radicals in beta-amyloidosis: an hypothesis. Neurobiol Aging. 1994 Jul-Aug;15(4):443–455. doi: 10.1016/0197-4580(94)90076-0. [DOI] [PubMed] [Google Scholar]
  67. Furukawa K., Abe Y., Akaike N. Amyloid beta protein-induced irreversible current in rat cortical neurones. Neuroreport. 1994 Oct 27;5(16):2016–2018. doi: 10.1097/00001756-199410270-00006. [DOI] [PubMed] [Google Scholar]
  68. Geddes A. J., Parker K. D., Atkins E. D., Beighton E. "Cross-beta" conformation in proteins. J Mol Biol. 1968 Mar 14;32(2):343–358. doi: 10.1016/0022-2836(68)90014-4. [DOI] [PubMed] [Google Scholar]
  69. Ghiso J., Matsubara E., Koudinov A., Choi-Miura N. H., Tomita M., Wisniewski T., Frangione B. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J. 1993 Jul 1;293(Pt 1):27–30. doi: 10.1042/bj2930027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Glenner G. G. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med. 1980 Jun 5;302(23):1283–1292. doi: 10.1056/NEJM198006053022305. [DOI] [PubMed] [Google Scholar]
  71. Goate A., Chartier-Harlin M. C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991 Feb 21;349(6311):704–706. doi: 10.1038/349704a0. [DOI] [PubMed] [Google Scholar]
  72. Golabek A., Marques M. A., Lalowski M., Wisniewski T. Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid. Neurosci Lett. 1995 May 19;191(1-2):79–82. doi: 10.1016/0304-3940(95)11565-7. [DOI] [PubMed] [Google Scholar]
  73. Goldgaber D., Harris H. W., Hla T., Maciag T., Donnelly R. J., Jacobsen J. S., Vitek M. P., Gajdusek D. C. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7606–7610. doi: 10.1073/pnas.86.19.7606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Goodman Y., Steiner M. R., Steiner S. M., Mattson M. P. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res. 1994 Aug 15;654(1):171–176. doi: 10.1016/0006-8993(94)91586-5. [DOI] [PubMed] [Google Scholar]
  75. Gorevic P. D., Castano E. M., Sarma R., Frangione B. Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern. Biochem Biophys Res Commun. 1987 Sep 15;147(2):854–862. doi: 10.1016/0006-291x(87)91008-4. [DOI] [PubMed] [Google Scholar]
  76. Greenberg C. S., Birckbichler P. J., Rice R. H. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 1991 Dec;5(15):3071–3077. doi: 10.1096/fasebj.5.15.1683845. [DOI] [PubMed] [Google Scholar]
  77. Greenlund L. J., Deckwerth T. L., Johnson E. M., Jr Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron. 1995 Feb;14(2):303–315. doi: 10.1016/0896-6273(95)90287-2. [DOI] [PubMed] [Google Scholar]
  78. Groner Y., Elroy-Stein O., Bernstein Y., Dafni N., Levanon D., Danciger E., Neer A. Molecular genetics of Down's syndrome: overexpression of transfected human Cu/Zn-superoxide dismutase gene and the consequent physiological changes. Cold Spring Harb Symp Quant Biol. 1986;51(Pt 1):381–393. doi: 10.1101/sqb.1986.051.01.046. [DOI] [PubMed] [Google Scholar]
  79. Haass C., Hung A. Y., Selkoe D. J., Teplow D. B. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem. 1994 Jul 1;269(26):17741–17748. [PubMed] [Google Scholar]
  80. Haass C., Selkoe D. J. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell. 1993 Dec 17;75(6):1039–1042. doi: 10.1016/0092-8674(93)90312-e. [DOI] [PubMed] [Google Scholar]
  81. Haga S., Akai K., Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol. 1989;77(6):569–575. doi: 10.1007/BF00687883. [DOI] [PubMed] [Google Scholar]
  82. Halliwell B., Gutteridge J. M., Cross C. E. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med. 1992 Jun;119(6):598–620. [PubMed] [Google Scholar]
  83. Halverson K., Fraser P. E., Kirschner D. A., Lansbury P. T., Jr Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments. Biochemistry. 1990 Mar 20;29(11):2639–2644. doi: 10.1021/bi00463a003. [DOI] [PubMed] [Google Scholar]
  84. Halvorson C., Hays A., Kraabel B., Wu R., Wudl F., Heeger A. J. A 160-femtosecond optical image processor based on a conjugated polymer. Science. 1994 Aug 26;265(5176):1215–1216. doi: 10.1126/science.265.5176.1215. [DOI] [PubMed] [Google Scholar]
  85. Hamazaki H. Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer's beta-amyloid peptide. J Biol Chem. 1995 May 5;270(18):10392–10394. doi: 10.1074/jbc.270.18.10392. [DOI] [PubMed] [Google Scholar]
  86. Han H., Weinreb P. H., Lansbury P. T., Jr The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem Biol. 1995 Mar;2(3):163–169. doi: 10.1016/1074-5521(95)90071-3. [DOI] [PubMed] [Google Scholar]
  87. Hartmann H., Eckert A., Müller W. E. Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity. Biochem Biophys Res Commun. 1994 May 16;200(3):1185–1192. doi: 10.1006/bbrc.1994.1576. [DOI] [PubMed] [Google Scholar]
  88. Hawtin S. R., Dobbins A. C., Tailor V. J., Shearman M. S. Beta-amyloid inhibition of MTT reduction is not mimicked by inhibitors of mitochondrial respiration. Biochem Soc Trans. 1995 Feb;23(1):56S–56S. doi: 10.1042/bst023056s. [DOI] [PubMed] [Google Scholar]
  89. Hendriks L., van Duijn C. M., Cras P., Cruts M., Van Hul W., van Harskamp F., Warren A., McInnis M. G., Antonarakis S. E., Martin J. J. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet. 1992 Jun;1(3):218–221. doi: 10.1038/ng0692-218. [DOI] [PubMed] [Google Scholar]
  90. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A., Butterfield D. A. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3270–3274. doi: 10.1073/pnas.91.8.3270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Hilbich C., Kisters-Woike B., Reed J., Masters C. L., Beyreuther K. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J Mol Biol. 1991 Mar 5;218(1):149–163. doi: 10.1016/0022-2836(91)90881-6. [DOI] [PubMed] [Google Scholar]
  92. Hilbich C., Kisters-Woike B., Reed J., Masters C. L., Beyreuther K. Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4. Eur J Biochem. 1991 Oct 1;201(1):61–69. doi: 10.1111/j.1432-1033.1991.tb16256.x. [DOI] [PubMed] [Google Scholar]
  93. Hilbich C., Kisters-Woike B., Reed J., Masters C. L., Beyreuther K. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. J Mol Biol. 1992 Nov 20;228(2):460–473. doi: 10.1016/0022-2836(92)90835-8. [DOI] [PubMed] [Google Scholar]
  94. Hyman B. T., Marzloff K., Arriagada P. V. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol. 1993 Nov;52(6):594–600. doi: 10.1097/00005072-199311000-00006. [DOI] [PubMed] [Google Scholar]
  95. Ikura K., Takahata K., Sasaki R. Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase. FEBS Lett. 1993 Jul 12;326(1-3):109–111. doi: 10.1016/0014-5793(93)81772-r. [DOI] [PubMed] [Google Scholar]
  96. Ishii T., Haga S. Complements, microglial cells and amyloid fibril formation. Res Immunol. 1992 Jul-Aug;143(6):614–616. doi: 10.1016/0923-2494(92)80043-k. [DOI] [PubMed] [Google Scholar]
  97. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H. A., Kittel A., Saitoh T. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995 Feb;14(2):467–475. doi: 10.1016/0896-6273(95)90302-x. [DOI] [PubMed] [Google Scholar]
  98. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 1994 Jul;13(1):45–53. doi: 10.1016/0896-6273(94)90458-8. [DOI] [PubMed] [Google Scholar]
  99. Jarrett J. T., Berger E. P., Lansbury P. T., Jr The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 1993 May 11;32(18):4693–4697. doi: 10.1021/bi00069a001. [DOI] [PubMed] [Google Scholar]
  100. Jarrett J. T., Lansbury P. T., Jr Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry. 1992 Dec 15;31(49):12345–12352. doi: 10.1021/bi00164a008. [DOI] [PubMed] [Google Scholar]
  101. Jarrett J. T., Lansbury P. T., Jr Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 1993 Jun 18;73(6):1055–1058. doi: 10.1016/0092-8674(93)90635-4. [DOI] [PubMed] [Google Scholar]
  102. Jiang H., Burdick D., Glabe C. G., Cotman C. W., Tenner A. J. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol. 1994 May 15;152(10):5050–5059. [PubMed] [Google Scholar]
  103. Joachim C. L., Duffy L. K., Morris J. H., Selkoe D. J. Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging. Brain Res. 1988 Nov 22;474(1):100–111. doi: 10.1016/0006-8993(88)90673-7. [DOI] [PubMed] [Google Scholar]
  104. Joslin G., Krause J. E., Hershey A. D., Adams S. P., Fallon R. J., Perlmutter D. H. Amyloid-beta peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor. J Biol Chem. 1991 Nov 15;266(32):21897–21902. [PubMed] [Google Scholar]
  105. Kalaria R. N., Perry G. Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease. Brain Res. 1993 Dec 17;631(1):151–155. doi: 10.1016/0006-8993(93)91202-4. [DOI] [PubMed] [Google Scholar]
  106. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., Müller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987 Feb 19;325(6106):733–736. doi: 10.1038/325733a0. [DOI] [PubMed] [Google Scholar]
  107. Kawahara M., Muramoto K., Kobayashi K., Mori H., Kuroda Y. Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro. Biochem Biophys Res Commun. 1994 Jan 28;198(2):531–535. doi: 10.1006/bbrc.1994.1078. [DOI] [PubMed] [Google Scholar]
  108. Kimura T., Takamatsu J., Araki N., Goto M., Kondo A., Miyakawa T., Horiuchi S. Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease? Neuroreport. 1995 Apr 19;6(6):866–868. doi: 10.1097/00001756-199504190-00010. [DOI] [PubMed] [Google Scholar]
  109. Kirschner D. A., Abraham C., Selkoe D. J. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. Proc Natl Acad Sci U S A. 1986 Jan;83(2):503–507. doi: 10.1073/pnas.83.2.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Kirschner D. A., Inouye H., Duffy L. K., Sinclair A., Lind M., Selkoe D. J. Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6953–6957. doi: 10.1073/pnas.84.19.6953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Kisilevsky R., Lemieux L. J., Fraser P. E., Kong X., Hultin P. G., Szarek W. A. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat Med. 1995 Feb;1(2):143–148. doi: 10.1038/nm0295-143. [DOI] [PubMed] [Google Scholar]
  112. Klapper M. H. The independent distribution of amino acid near neighbor pairs into polypeptides. Biochem Biophys Res Commun. 1977 Oct 10;78(3):1018–1024. doi: 10.1016/0006-291x(77)90523-x. [DOI] [PubMed] [Google Scholar]
  113. Klegeris A., Walker D. G., McGeer P. L. Activation of macrophages by Alzheimer beta amyloid peptide. Biochem Biophys Res Commun. 1994 Mar 15;199(2):984–991. doi: 10.1006/bbrc.1994.1326. [DOI] [PubMed] [Google Scholar]
  114. Klunk W. E., Pettegrew J. W., Abraham D. J. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J Histochem Cytochem. 1989 Aug;37(8):1273–1281. doi: 10.1177/37.8.2666510. [DOI] [PubMed] [Google Scholar]
  115. Knauer M. F., Soreghan B., Burdick D., Kosmoski J., Glabe C. G. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7437–7441. doi: 10.1073/pnas.89.16.7437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Kobayashi T., Abe K., Saito H., Nishiyama N. Effect of alpha 1-antichymotrypsin on the toxicity of beta-amyloid fragment 25-40 in rat primary cultured neurons. Neurosci Lett. 1994 May 19;172(1-2):147–150. doi: 10.1016/0304-3940(94)90683-1. [DOI] [PubMed] [Google Scholar]
  117. Koh J. Y., Yang L. L., Cotman C. W. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 1990 Nov 19;533(2):315–320. doi: 10.1016/0006-8993(90)91355-k. [DOI] [PubMed] [Google Scholar]
  118. Kowall N. W., Beal M. F., Busciglio J., Duffy L. K., Yankner B. A. An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7247–7251. doi: 10.1073/pnas.88.16.7247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Kowall N. W., McKee A. C., Yankner B. A., Beal M. F. In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment. Neurobiol Aging. 1992 Sep-Oct;13(5):537–542. doi: 10.1016/0197-4580(92)90053-z. [DOI] [PubMed] [Google Scholar]
  120. Kozlowski M. R., Spanoyannis A., Manly S. P., Fidel S. A., Neve R. L. The neurotoxic carboxy-terminal fragment of the Alzheimer amyloid precursor binds specifically to a neuronal cell surface molecule: pH dependence of the neurotoxicity and the binding. J Neurosci. 1992 May;12(5):1679–1687. doi: 10.1523/JNEUROSCI.12-05-01679.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. LaDu M. J., Falduto M. T., Manelli A. M., Reardon C. A., Getz G. S., Frail D. E. Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem. 1994 Sep 23;269(38):23403–23406. [PubMed] [Google Scholar]
  122. LaDu M. J., Pederson T. M., Frail D. E., Reardon C. A., Getz G. S., Falduto M. T. Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid. J Biol Chem. 1995 Apr 21;270(16):9039–9042. doi: 10.1074/jbc.270.16.9039. [DOI] [PubMed] [Google Scholar]
  123. Ladror U. S., Snyder S. W., Wang G. T., Holzman T. F., Krafft G. A. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. J Biol Chem. 1994 Jul 15;269(28):18422–18428. [PubMed] [Google Scholar]
  124. Lannfelt L., Folkesson R., Mohammed A. H., Winblad B., Hellgren D., Duff K., Hardy J. Alzheimer's disease: molecular genetics and transgenic animal models. Behav Brain Res. 1993 Nov 30;57(2):207–213. doi: 10.1016/0166-4328(93)90137-f. [DOI] [PubMed] [Google Scholar]
  125. Lansbury P. T., Jr In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information. Biochemistry. 1992 Aug 4;31(30):6865–6870. doi: 10.1021/bi00145a001. [DOI] [PubMed] [Google Scholar]
  126. Lansbury P. T., Jr In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information. Biochemistry. 1992 Aug 4;31(30):6865–6870. doi: 10.1021/bi00145a001. [DOI] [PubMed] [Google Scholar]
  127. LeVine H., 3rd Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993 Mar;2(3):404–410. doi: 10.1002/pro.5560020312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Lee J. P., Stimson E. R., Ghilardi J. R., Mantyh P. W., Lu Y. A., Felix A. M., Llanos W., Behbin A., Cummings M., Van Criekinge M. 1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence. Biochemistry. 1995 Apr 18;34(15):5191–5200. doi: 10.1021/bi00015a033. [DOI] [PubMed] [Google Scholar]
  129. Leveugle B., Scanameo A., Ding W., Fillit H. Binding of heparan sulfate glycosaminoglycan to beta-amyloid peptide: inhibition by potentially therapeutic polysulfated compounds. Neuroreport. 1994 Jun 27;5(11):1389–1392. [PubMed] [Google Scholar]
  130. Levy E., Carman M. D., Fernandez-Madrid I. J., Power M. D., Lieberburg I., van Duinen S. G., Bots G. T., Luyendijk W., Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 1990 Jun 1;248(4959):1124–1126. doi: 10.1126/science.2111584. [DOI] [PubMed] [Google Scholar]
  131. Lockhart B. P., Benicourt C., Junien J. L., Privat A. Inhibitors of free radical formation fail to attenuate direct beta-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures. J Neurosci Res. 1994 Nov 1;39(4):494–505. doi: 10.1002/jnr.490390416. [DOI] [PubMed] [Google Scholar]
  132. Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J., Cotman C. W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7951–7955. doi: 10.1073/pnas.90.17.7951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Lorenzo A., Razzaboni B., Weir G. C., Yankner B. A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 1994 Apr 21;368(6473):756–760. doi: 10.1038/368756a0. [DOI] [PubMed] [Google Scholar]
  134. Ma J., Yee A., Brewer H. B., Jr, Das S., Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 1994 Nov 3;372(6501):92–94. doi: 10.1038/372092a0. [DOI] [PubMed] [Google Scholar]
  135. Maggio J. E., Stimson E. R., Ghilardi J. R., Allen C. J., Dahl C. E., Whitcomb D. C., Vigna S. R., Vinters H. V., Labenski M. E., Mantyh P. W. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5462–5466. doi: 10.1073/pnas.89.12.5462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Mah S. P., Zhong L. T., Liu Y., Roghani A., Edwards R. H., Bredesen D. E. The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J Neurochem. 1993 Mar;60(3):1183–1186. doi: 10.1111/j.1471-4159.1993.tb03275.x. [DOI] [PubMed] [Google Scholar]
  137. Mahley R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988 Apr 29;240(4852):622–630. doi: 10.1126/science.3283935. [DOI] [PubMed] [Google Scholar]
  138. Mantyh P. W., Ghilardi J. R., Rogers S., DeMaster E., Allen C. J., Stimson E. R., Maggio J. E. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem. 1993 Sep;61(3):1171–1174. doi: 10.1111/j.1471-4159.1993.tb03639.x. [DOI] [PubMed] [Google Scholar]
  139. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245–4249. doi: 10.1073/pnas.82.12.4245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Matsubara E., Frangione B., Ghiso J. Characterization of apolipoprotein J-Alzheimer's A beta interaction. J Biol Chem. 1995 Mar 31;270(13):7563–7567. doi: 10.1074/jbc.270.13.7563. [DOI] [PubMed] [Google Scholar]
  141. Mattson M. P., Barger S. W., Cheng B., Lieberburg I., Smith-Swintosky V. L., Rydel R. E. beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci. 1993 Oct;16(10):409–414. doi: 10.1016/0166-2236(93)90009-b. [DOI] [PubMed] [Google Scholar]
  142. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R. E. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci. 1992 Feb;12(2):376–389. doi: 10.1523/JNEUROSCI.12-02-00376.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Mattson M. P., Goodman Y. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res. 1995 Apr 3;676(1):219–224. doi: 10.1016/0006-8993(95)00148-j. [DOI] [PubMed] [Google Scholar]
  144. Mattson M. P., Rydel R. E. beta-Amyloid precursor protein and Alzheimer's disease: the peptide plot thickens. Neurobiol Aging. 1992 Sep-Oct;13(5):617–621. doi: 10.1016/0197-4580(92)90068-9. [DOI] [PubMed] [Google Scholar]
  145. Mattson M. P., Tomaselli K. J., Rydel R. E. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res. 1993 Sep 3;621(1):35–49. doi: 10.1016/0006-8993(93)90295-x. [DOI] [PubMed] [Google Scholar]
  146. May P. C., Boggs L. N., Fuson K. S. Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity. J Neurochem. 1993 Dec;61(6):2330–2333. doi: 10.1111/j.1471-4159.1993.tb07480.x. [DOI] [PubMed] [Google Scholar]
  147. McCubbin W. D., Kay C. M., Narindrasorasak S., Kisilevsky R. Circular-dichroism studies on two murine serum amyloid A proteins. Biochem J. 1988 Dec 15;256(3):775–783. doi: 10.1042/bj2560775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. McGeer P. L., Akiyama H., Itagaki S., McGeer E. G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett. 1989 Dec 15;107(1-3):341–346. doi: 10.1016/0304-3940(89)90843-4. [DOI] [PubMed] [Google Scholar]
  149. Meda L., Cassatella M. A., Szendrei G. I., Otvos L., Jr, Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature. 1995 Apr 13;374(6523):647–650. doi: 10.1038/374647a0. [DOI] [PubMed] [Google Scholar]
  150. Merz P. A., Wisniewski H. M., Somerville R. A., Bobin S. A., Masters C. L., Iqbal K. Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol. 1983;60(1-2):113–124. doi: 10.1007/BF00685355. [DOI] [PubMed] [Google Scholar]
  151. Mirzabekov T., Lin M. C., Yuan W. L., Marshall P. J., Carman M., Tomaselli K., Lieberburg I., Kagan B. L. Channel formation in planar lipid bilayers by a neurotoxic fragment of the beta-amyloid peptide. Biochem Biophys Res Commun. 1994 Jul 29;202(2):1142–1148. doi: 10.1006/bbrc.1994.2047. [DOI] [PubMed] [Google Scholar]
  152. Monnier V. M., Cerami A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science. 1981 Jan 30;211(4481):491–493. doi: 10.1126/science.6779377. [DOI] [PubMed] [Google Scholar]
  153. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet. 1992 Aug;1(5):345–347. doi: 10.1038/ng0892-345. [DOI] [PubMed] [Google Scholar]
  154. Murrell J., Farlow M., Ghetti B., Benson M. D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 1991 Oct 4;254(5028):97–99. doi: 10.1126/science.1925564. [DOI] [PubMed] [Google Scholar]
  155. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991 Feb 8;541(1):163–166. doi: 10.1016/0006-8993(91)91092-f. [DOI] [PubMed] [Google Scholar]
  156. Nikkhah G., Tonn J. C., Hoffmann O., Kraemer H. P., Darling J. L., Schönmayr R., Schachenmayr W. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables. J Neurooncol. 1992 May;13(1):1–11. doi: 10.1007/BF00172941. [DOI] [PubMed] [Google Scholar]
  157. Olanow C. W. A radical hypothesis for neurodegeneration. Trends Neurosci. 1993 Nov;16(11):439–444. doi: 10.1016/0166-2236(93)90070-3. [DOI] [PubMed] [Google Scholar]
  158. Otvos L., Jr, Szendrei G. I., Lee V. M., Mantsch H. H. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents. Eur J Biochem. 1993 Jan 15;211(1-2):249–257. doi: 10.1111/j.1432-1033.1993.tb19893.x. [DOI] [PubMed] [Google Scholar]
  159. Perlmutter D. H., Pierce J. A. The alpha 1-antitrypsin gene and emphysema. Am J Physiol. 1989 Oct;257(4 Pt 1):L147–L162. doi: 10.1152/ajplung.1989.257.4.L147. [DOI] [PubMed] [Google Scholar]
  160. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., Cotman C. W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci. 1993 Apr;13(4):1676–1687. doi: 10.1523/JNEUROSCI.13-04-01676.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Pike C. J., Cotman C. W. Calretinin-immunoreactive neurons are resistant to beta-amyloid toxicity in vitro. Brain Res. 1995 Feb 13;671(2):293–298. doi: 10.1016/0006-8993(94)01354-k. [DOI] [PubMed] [Google Scholar]
  162. Pike C. J., Cotman C. W. Cultured GABA-immunoreactive neurons are resistant to toxicity induced by beta-amyloid. Neuroscience. 1993 Sep;56(2):269–274. doi: 10.1016/0306-4522(93)90331-9. [DOI] [PubMed] [Google Scholar]
  163. Pike C. J., Walencewicz-Wasserman A. J., Kosmoski J., Cribbs D. H., Glabe C. G., Cotman C. W. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem. 1995 Jan;64(1):253–265. doi: 10.1046/j.1471-4159.1995.64010253.x. [DOI] [PubMed] [Google Scholar]
  164. Pike C. J., Walencewicz A. J., Glabe C. G., Cotman C. W. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur J Pharmacol. 1991 Aug 14;207(4):367–368. doi: 10.1016/0922-4106(91)90014-9. [DOI] [PubMed] [Google Scholar]
  165. Pike C. J., Walencewicz A. J., Glabe C. G., Cotman C. W. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 1991 Nov 1;563(1-2):311–314. doi: 10.1016/0006-8993(91)91553-d. [DOI] [PubMed] [Google Scholar]
  166. Podlisny M. B., Ostaszewski B. L., Squazzo S. L., Koo E. H., Rydell R. E., Teplow D. B., Selkoe D. J. Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem. 1995 Apr 21;270(16):9564–9570. doi: 10.1074/jbc.270.16.9564. [DOI] [PubMed] [Google Scholar]
  167. Pollack S. J., Sadler I. I., Hawtin S. R., Tailor V. J., Shearman M. S. Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells. Neurosci Lett. 1995 Jan 23;184(2):113–116. doi: 10.1016/0304-3940(94)11182-i. [DOI] [PubMed] [Google Scholar]
  168. Prelli F., Castaño E., Glenner G. G., Frangione B. Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem. 1988 Aug;51(2):648–651. doi: 10.1111/j.1471-4159.1988.tb01087.x. [DOI] [PubMed] [Google Scholar]
  169. Quon D., Catalano R., Cordell B. Fibroblast growth factor induces beta-amyloid precursor mRNA in glial but not neuronal cultured cells. Biochem Biophys Res Commun. 1990 Feb 28;167(1):96–102. doi: 10.1016/0006-291x(90)91735-b. [DOI] [PubMed] [Google Scholar]
  170. Rasmussen L. K., Sørensen E. S., Petersen T. E., Gliemann J., Jensen P. H. Identification of glutamine and lysine residues in Alzheimer amyloid beta A4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to alpha 2M receptor. FEBS Lett. 1994 Jan 31;338(2):161–166. doi: 10.1016/0014-5793(94)80356-0. [DOI] [PubMed] [Google Scholar]
  171. Rogers J., Cooper N. R., Webster S., Schultz J., McGeer P. L., Styren S. D., Civin W. H., Brachova L., Bradt B., Ward P. Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10016–10020. doi: 10.1073/pnas.89.21.10016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Roher A. E., Ball M. J., Bhave S. V., Wakade A. R. Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. Biochem Biophys Res Commun. 1991 Jan 31;174(2):572–579. doi: 10.1016/0006-291x(91)91455-l. [DOI] [PubMed] [Google Scholar]
  173. Roher A. E., Lowenson J. D., Clarke S., Wolkow C., Wang R., Cotter R. J., Reardon I. M., Zürcher-Neely H. A., Heinrikson R. L., Ball M. J. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem. 1993 Feb 15;268(5):3072–3083. [PubMed] [Google Scholar]
  174. Roher A. E., Lowenson J. D., Clarke S., Woods A. S., Cotter R. J., Gowing E., Ball M. J. beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10836–10840. doi: 10.1073/pnas.90.22.10836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Rothstein J. D., Bristol L. A., Hosler B., Brown R. H., Jr, Kuncl R. W. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4155–4159. doi: 10.1073/pnas.91.10.4155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. SLATER T. F., SAWYER B., STRAEULI U. STUDIES ON SUCCINATE-TETRAZOLIUM REDUCTASE SYSTEMS. III. POINTS OF COUPLING OF FOUR DIFFERENT TETRAZOLIUM SALTS. Biochim Biophys Acta. 1963 Nov 8;77:383–393. doi: 10.1016/0006-3002(63)90513-4. [DOI] [PubMed] [Google Scholar]
  177. Sanan D. A., Weisgraber K. H., Russell S. J., Mahley R. W., Huang D., Saunders A., Schmechel D., Wisniewski T., Frangione B., Roses A. D. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest. 1994 Aug;94(2):860–869. doi: 10.1172/JCI117407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Schmechel D. E., Saunders A. M., Strittmatter W. J., Crain B. J., Hulette C. M., Joo S. H., Pericak-Vance M. A., Goldgaber D., Roses A. D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9649–9653. doi: 10.1073/pnas.90.20.9649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Schultz J., Schaller J., McKinley M., Bradt B., Cooper N., May P., Rogers J. Enhanced cytotoxicity of amyloid beta-peptide by a complement dependent mechanism. Neurosci Lett. 1994 Jul 4;175(1-2):99–102. doi: 10.1016/0304-3940(94)91088-x. [DOI] [PubMed] [Google Scholar]
  180. Schwarzman A. L., Gregori L., Vitek M. P., Lyubski S., Strittmatter W. J., Enghilde J. J., Bhasin R., Silverman J., Weisgraber K. H., Coyle P. K. Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8368–8372. doi: 10.1073/pnas.91.18.8368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Selkoe D. J., Abraham C. R., Podlisny M. B., Duffy L. K. Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J Neurochem. 1986 Jun;46(6):1820–1834. doi: 10.1111/j.1471-4159.1986.tb08501.x. [DOI] [PubMed] [Google Scholar]
  182. Selkoe D. J. Amyloid beta-protein precursor: new clues to the genesis of Alzheimer's disease. Curr Opin Neurobiol. 1994 Oct;4(5):708–716. doi: 10.1016/0959-4388(94)90014-0. [DOI] [PubMed] [Google Scholar]
  183. Shearman M. S., Ragan C. I., Iversen L. L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1470–1474. doi: 10.1073/pnas.91.4.1470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Shen C. L., Scott G. L., Merchant F., Murphy R. M. Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide. Biophys J. 1993 Dec;65(6):2383–2395. doi: 10.1016/S0006-3495(93)81312-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Shivers B. D., Hilbich C., Multhaup G., Salbaum M., Beyreuther K., Seeburg P. H. Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J. 1988 May;7(5):1365–1370. doi: 10.1002/j.1460-2075.1988.tb02952.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Simmons L. K., May P. C., Tomaselli K. J., Rydel R. E., Fuson K. S., Brigham E. F., Wright S., Lieberburg I., Becker G. W., Brems D. N. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol Pharmacol. 1994 Mar;45(3):373–379. [PubMed] [Google Scholar]
  187. Simmons M. A., Schneider C. R. Amyloid beta peptides act directly on single neurons. Neurosci Lett. 1993 Feb 19;150(2):133–136. doi: 10.1016/0304-3940(93)90519-q. [DOI] [PubMed] [Google Scholar]
  188. Smith M. A., Taneda S., Richey P. L., Miyata S., Yan S. D., Stern D., Sayre L. M., Monnier V. M., Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5710–5714. doi: 10.1073/pnas.91.12.5710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Snow A. D., Wight T. N. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses. Neurobiol Aging. 1989 Sep-Oct;10(5):481–497. doi: 10.1016/0197-4580(89)90108-5. [DOI] [PubMed] [Google Scholar]
  190. Snyder S. W., Ladror U. S., Wade W. S., Wang G. T., Barrett L. W., Matayoshi E. D., Huffaker H. J., Krafft G. A., Holzman T. F. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J. 1994 Sep;67(3):1216–1228. doi: 10.1016/S0006-3495(94)80591-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Soto C., Castaño E. M., Frangione B., Inestrosa N. C. The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation. J Biol Chem. 1995 Feb 17;270(7):3063–3067. doi: 10.1074/jbc.270.7.3063. [DOI] [PubMed] [Google Scholar]
  192. Spencer R. G., Halverson K. J., Auger M., McDermott A. E., Griffin R. G., Lansbury P. T., Jr An unusual peptide conformation may precipitate amyloid formation in Alzheimer's disease: application of solid-state NMR to the determination of protein secondary structure. Biochemistry. 1991 Oct 29;30(43):10382–10387. doi: 10.1021/bi00107a004. [DOI] [PubMed] [Google Scholar]
  193. Strittmatter W. J., Huang D. Y., Bhasin R., Roses A. D., Goldgaber D. Avid binding of beta A amyloid peptide to its own precursor. Exp Neurol. 1993 Aug;122(2):327–334. doi: 10.1006/exnr.1993.1132. [DOI] [PubMed] [Google Scholar]
  194. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977–1981. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., Roses A. D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8098–8102. doi: 10.1073/pnas.90.17.8098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Su J. H., Anderson A. J., Cummings B. J., Cotman C. W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport. 1994 Dec 20;5(18):2529–2533. doi: 10.1097/00001756-199412000-00031. [DOI] [PubMed] [Google Scholar]
  197. Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L., Jr, Eckman C., Golde T. E., Younkin S. G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 1994 May 27;264(5163):1336–1340. doi: 10.1126/science.8191290. [DOI] [PubMed] [Google Scholar]
  198. Takadera T., Sakura N., Mohri T., Hashimoto T. Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention. Neurosci Lett. 1993 Oct 14;161(1):41–44. doi: 10.1016/0304-3940(93)90135-8. [DOI] [PubMed] [Google Scholar]
  199. Takashima A., Noguchi K., Sato K., Hoshino T., Imahori K. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7789–7793. doi: 10.1073/pnas.90.16.7789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Talafous J., Marcinowski K. J., Klopman G., Zagorski M. G. Solution structure of residues 1-28 of the amyloid beta-peptide. Biochemistry. 1994 Jun 28;33(25):7788–7796. doi: 10.1021/bi00191a006. [DOI] [PubMed] [Google Scholar]
  201. Tanzi R. E., Vaula G., Romano D. M., Mortilla M., Huang T. L., Tupler R. G., Wasco W., Hyman B. T., Haines J. L., Jenkins B. J. Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet. 1992 Aug;51(2):273–282. [PMC free article] [PubMed] [Google Scholar]
  202. Tennent G. A., Lovat L. B., Pepys M. B. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4299–4303. doi: 10.1073/pnas.92.10.4299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Terzi E., Hölzemann G., Seelig J. Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes. Biochemistry. 1994 Jun 14;33(23):7434–7441. doi: 10.1021/bi00189a051. [DOI] [PubMed] [Google Scholar]
  204. Tomiyama T., Asano S., Furiya Y., Shirasawa T., Endo N., Mori H. Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues. J Biol Chem. 1994 Apr 8;269(14):10205–10208. [PubMed] [Google Scholar]
  205. Tomski S. J., Murphy R. M. Kinetics of aggregation of synthetic beta-amyloid peptide. Arch Biochem Biophys. 1992 May 1;294(2):630–638. doi: 10.1016/0003-9861(92)90735-f. [DOI] [PubMed] [Google Scholar]
  206. Troy C. M., Shelanski M. L. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6384–6387. doi: 10.1073/pnas.91.14.6384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Ueda K., Fukui Y., Kageyama H. Amyloid beta protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid beta protein. Brain Res. 1994 Mar 14;639(2):240–244. doi: 10.1016/0006-8993(94)91736-1. [DOI] [PubMed] [Google Scholar]
  208. Uéda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D. A., Kondo J., Ihara Y., Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11282–11286. doi: 10.1073/pnas.90.23.11282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Van Broeckhoven C., Haan J., Bakker E., Hardy J. A., Van Hul W., Wehnert A., Vegter-Van der Vlis M., Roos R. A. Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science. 1990 Jun 1;248(4959):1120–1122. doi: 10.1126/science.1971458. [DOI] [PubMed] [Google Scholar]
  210. Vitek M. P., Bhattacharya K., Glendening J. M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4766–4770. doi: 10.1073/pnas.91.11.4766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Volicer L., Crino P. B. Involvement of free radicals in dementia of the Alzheimer type: a hypothesis. Neurobiol Aging. 1990 Sep-Oct;11(5):567–571. doi: 10.1016/0197-4580(90)90119-k. [DOI] [PubMed] [Google Scholar]
  212. Vyas S. B., Duffy L. K. Stabilization of secondary structure of Alzheimer beta-protein by aluminum(III) ions and D-Asp substitutions. Biochem Biophys Res Commun. 1995 Jan 17;206(2):718–723. doi: 10.1006/bbrc.1995.1101. [DOI] [PubMed] [Google Scholar]
  213. Watt J. A., Pike C. J., Walencewicz-Wasserman A. J., Cotman C. W. Ultrastructural analysis of beta-amyloid-induced apoptosis in cultured hippocampal neurons. Brain Res. 1994 Oct 24;661(1-2):147–156. doi: 10.1016/0006-8993(94)91191-6. [DOI] [PubMed] [Google Scholar]
  214. Webster S., O'Barr S., Rogers J. Enhanced aggregation and beta structure of amyloid beta peptide after coincubation with C1q. J Neurosci Res. 1994 Nov 1;39(4):448–456. doi: 10.1002/jnr.490390412. [DOI] [PubMed] [Google Scholar]
  215. Weiss J. H., Pike C. J., Cotman C. W. Ca2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture. J Neurochem. 1994 Jan;62(1):372–375. doi: 10.1046/j.1471-4159.1994.62010372.x. [DOI] [PubMed] [Google Scholar]
  216. Whitson J. S., Glabe C. G., Shintani E., Abcar A., Cotman C. W. Beta-amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci Lett. 1990 Mar 14;110(3):319–324. doi: 10.1016/0304-3940(90)90867-9. [DOI] [PubMed] [Google Scholar]
  217. Whitson J. S., Mims M. P., Strittmatter W. J., Yamaki T., Morrisett J. D., Appel S. H. Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E. Biochem Biophys Res Commun. 1994 Feb 28;199(1):163–170. doi: 10.1006/bbrc.1994.1209. [DOI] [PubMed] [Google Scholar]
  218. Whitson J. S., Selkoe D. J., Cotman C. W. Amyloid beta protein enhances the survival of hippocampal neurons in vitro. Science. 1989 Mar 17;243(4897):1488–1490. doi: 10.1126/science.2928783. [DOI] [PubMed] [Google Scholar]
  219. Whittemore E. R., Loo D. T., Cotman C. W. Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. Neuroreport. 1994 Jul 21;5(12):1485–1488. doi: 10.1097/00001756-199407000-00019. [DOI] [PubMed] [Google Scholar]
  220. Wisniewski K. E., Wisniewski H. M., Wen G. Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol. 1985 Mar;17(3):278–282. doi: 10.1002/ana.410170310. [DOI] [PubMed] [Google Scholar]
  221. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 1992 Feb 3;135(2):235–238. doi: 10.1016/0304-3940(92)90444-c. [DOI] [PubMed] [Google Scholar]
  222. Wisniewski T., Ghiso J., Frangione B. Alzheimer's disease and soluble A beta. Neurobiol Aging. 1994 Mar-Apr;15(2):143–152. doi: 10.1016/0197-4580(94)90105-8. [DOI] [PubMed] [Google Scholar]
  223. Wisniewski T., Ghiso J., Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun. 1991 Sep 30;179(3):1247–1254. doi: 10.1016/0006-291x(91)91706-i. [DOI] [PubMed] [Google Scholar]
  224. Wisniewski T., Golabek A., Matsubara E., Ghiso J., Frangione B. Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem Biophys Res Commun. 1993 Apr 30;192(2):359–365. doi: 10.1006/bbrc.1993.1423. [DOI] [PubMed] [Google Scholar]
  225. Wood S. J., Wetzel R., Martin J. D., Hurle M. R. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4. Biochemistry. 1995 Jan 24;34(3):724–730. doi: 10.1021/bi00003a003. [DOI] [PubMed] [Google Scholar]
  226. Yamada T., Sasaki H., Furuya H., Miyata T., Goto I., Sakaki Y. Complementary DNA for the mouse homolog of the human amyloid beta protein precursor. Biochem Biophys Res Commun. 1987 Dec 16;149(2):665–671. doi: 10.1016/0006-291x(87)90419-0. [DOI] [PubMed] [Google Scholar]
  227. Yankner B. A., Duffy L. K., Kirschner D. A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science. 1990 Oct 12;250(4978):279–282. doi: 10.1126/science.2218531. [DOI] [PubMed] [Google Scholar]
  228. Zagorski M. G., Barrow C. J. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment. Biochemistry. 1992 Jun 23;31(24):5621–5631. doi: 10.1021/bi00139a028. [DOI] [PubMed] [Google Scholar]
  229. Zhang Z., Drzewiecki G. J., Hom J. T., May P. C., Hyslop P. A. Human cortical neuronal (HCN) cell lines: a model for amyloid beta neurotoxicity. Neurosci Lett. 1994 Aug 15;177(1-2):162–164. doi: 10.1016/0304-3940(94)90892-3. [DOI] [PubMed] [Google Scholar]
  230. Zhao X., Valantas J. A., Vyas S., Duffy L. K. Comparative toxicity of amyloid beta-peptide in neuroblastoma cell lines: effects of albumin and physalaemin. Comp Biochem Physiol C. 1993 Sep;106(1):165–170. doi: 10.1016/0742-8413(93)90268-p. [DOI] [PubMed] [Google Scholar]
  231. Zhong L. T., Sarafian T., Kane D. J., Charles A. C., Mah S. P., Edwards R. H., Bredesen D. E. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4533–4537. doi: 10.1073/pnas.90.10.4533. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES